Elsevier

Atherosclerosis

Volume 253, October 2016, Pages 281-344
Atherosclerosis

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

https://doi.org/10.1016/j.atherosclerosis.2016.08.018Get rights and content

Keywords

dyslipidaemias
cholesterol
triglycerides
low-density lipoproteins
high-density lipoproteins
apolipoprotein B
lipoprotein remnants
total cardiovascular risk
treatment, lifestyle
treatment, drugs
treatment, adherence

Cited by (0)

ESC Committee for Practice Guidelines (CPG) and National Cardiac Society Reviewers can be found in the Appendix.

ESC entities having participated in the development of this document:

Associations: Acute Cardiovascular Care Association (ACCA), European Association for Cardiovascular Prevention & Rehabilitation (EACPR), European Association of Cardiovascular Imaging (EACVI), European Association of Percutaneous Cardiovascular Interventions (EAPCI), Heart Failure Association (HFA)

Councils: Council on Cardiovascular Nursing and Allied Professions, Council for Cardiology Practice, Council on Cardiovascular Primary Care, Council on Hypertension

Working Groups: Atherosclerosis & Vascular Biology, Cardiovascular Pharmacotherapy, Coronary Pathophysiology & Microcirculation, E-cardiology, Myocardial and Pericardial Diseases, Peripheral Circulation, Thrombosis.

The content of these European Society of Cardiology (ESC) and European Atherosclerosis Society Guidelines has been published for personal and educational use only. No commercial use is authorized. No part of the ESC Guidelines may be translated or reproduced in any form without written permission from the ESC. Permission can be obtained upon submission of a written request to Oxford University Press, the publisher of the European Heart Journal and the party authorized to handle such permissions on behalf of the ESC ([email protected]).

Disclaimer: The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient’s health condition and in consultation with that patient and, where appropriate and/or necessary, the patient’s caregiver. Nor do the ESC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities in order to manage each patient’s case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional’s responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.

Additional Contributor: Marie Therese Cooney (Ireland)

Document Reviewers: Lina Badimon (CPG Review Coordinator) (Spain), Christian Funck-Brentano (CPG Review Coordinator) (France), Stefan Agewall (Norway), Gonzalo Barón-Esquivias (Spain), Jan Borén (Sweden), Eric Bruckert (France), Alberto Cordero (Spain), Alberto Corsini (Italy), Pantaleo Giannuzzi (Italy), François Gueyffier (France), Goran Krstačić (Croatia), Maddalena Lettino (Italy), Christos Lionis (Greece), Gregory Y. H. Lip (UK), Pedro Marques-Vidal (Switzerland), Davor Milicic (Croatia), Juan Pedro-Botet (Spain), Massimo F. Piepoli (Italy), Angelos G. Rigopoulos (Germany), Frank Ruschitzka (Switzerland), José Tuñón (Spain), Arnold von Eckardstein (Switzerland), Michal Vrablik (Czech Republic), Thomas W. Weiss (Austria), Bryan Williams (UK), Stephan Windecker (Switzerland), Reuven Zimlichman (Israel)

The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org/guidelines.

View Abstract